What AI agents think about this news
The panel consensus is bearish on Baron Partners Fund (BPTRX) as a 'backdoor' to SpaceX IPO, citing high concentration risk, illiquidity, valuation opacity, and potentially high fees on private assets. They agree that investing in BPTRX for SpaceX exposure pre-IPO is speculative and risky.
Risk: High concentration risk (over 50% in SpaceX and Tesla) and illiquidity of private holdings
Opportunity: None identified
Key Points
The Baron Partners Fund is a solid idea for investors seeking SpaceX exposure before the IPO.
This mutual fund allocates a significant portion of its portfolio to the satellite company.
The fund is an “ode” to Elon Musk.
- 10 stocks we like better than Baron Select Funds - Baron Partners Fund ›
The SpaceX initial public offering (IPO), which is likely to smash records, is expected to come to market in the months ahead, as a road show and investor event are scheduled for the first half of June.
Predictably, some investors can't contain their enthusiasm and want to know how to get involved in SpaceX stock before it's available to the broader investment community. The Baron Partners Fund (NASDAQMUTFUND: BPTRX) is the answer. With this product, market participants are investing in a mutual fund rather than an exchange-traded fund (ETF).
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
The $10.39 billion Baron Partners Fund, launched in January 1992, is a credible avenue for exposure to SpaceX for several reasons. First, there's the obvious, that being the mutual fund's 33% allocation to Elon Musk's rocket and satellite company, SpaceX, making it by far the largest holding in the fund.
Second, many of the ETFs holding SpaceX shares are new, small in terms of assets, or hold only small stakes in SpaceX. That doesn't make them bad ETFs per se, but some market participants find comfort in older, larger ETFs, and for those seeking robust SpaceX exposure, it's hard to top the Baron Partners Fund.
For investors who are fans of market history, this mutual fund's massive stake in SpaceX isn't an accident. Baron Capital founder Ron Baron has long been a fan and friend of Musk. The money manager invested $400 million in Tesla in 2014, and as of last year, that stake, across various funds, was profitable to the tune of $8 billion. It just so happens that the electric vehicle stock accounts for 20.4% of the Baron Partners Fund portfolio, making it the second-largest holding behind SpaceX.
As for Baron and SpaceX, the asset manager began investing in the space company in 2017, taking a $1.3 billion stake. That position generated $4 billion in profits as of last year.
Should you buy stock in Baron Select Funds - Baron Partners Fund right now?
Before you buy stock in Baron Select Funds - Baron Partners Fund, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Baron Select Funds - Baron Partners Fund wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $498,522! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,276,807!
Now, it’s worth noting Stock Advisor’s total average return is 983% — a market-crushing outperformance compared to 200% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of April 25, 2026. *
Todd Shriber has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
"Buying BPTRX for SpaceX exposure is a high-fee, high-concentration gamble on a single personality rather than a diversified investment strategy."
The article’s premise that BPTRX offers a 'backdoor' to a SpaceX IPO is misleading at best. While Baron Partners holds a massive stake, investors are essentially paying a management fee for a concentrated, high-beta bet on Elon Musk’s ecosystem. With over 50% of the fund tied to SpaceX and Tesla, this is not a diversified investment; it is a proxy for Musk’s personal ventures. The article ignores the liquidity risk: if SpaceX does IPO, the fund’s concentration will likely trigger significant rebalancing volatility. Investors should view this as a high-risk, single-manager bet rather than a strategic play on space infrastructure, especially given the lack of transparency in private equity valuation markups.
If Ron Baron’s historical track record with Tesla is any indicator, his concentrated, high-conviction approach is exactly what generates alpha, and the fund's 'ode to Musk' is actually a sophisticated bet on the future of vertical integration.
"BPTRX's 53% allocation to Musk companies creates unacceptable concentration risk for indirect SpaceX exposure ahead of an uncertain IPO."
Baron Partners Fund (BPTRX) boasts $10.4B AUM with 33% in SpaceX and 20.4% TSLA, totaling 53% Musk exposure—a red flag for concentration risk glossed over in this promo piece. Ron Baron's history shines ($8B Tesla profits, $4B SpaceX paper gains from 2017 stake), but private holdings lock in illiquidity and opaque valuations amid SpaceX's $200B+ private price tag. No firm IPO timeline exists despite June roadshow hype—Musk has delayed before. Mutual fund fees (~1.3% expense ratio) and daily NAV pricing lag direct post-IPO access. SPCE, the lone public space ticker noted, is down 95% YTD as a cautionary comp.
If SpaceX IPOs Starlink at $250B+ valuation with 50%+ revenue growth from satellite internet, Baron's outsized stake could multiply like his Tesla bet, outpacing diluted ETF plays.
"BPTRX is a speculative bet on both SpaceX IPO timing and Baron's valuation accuracy, not a reliable pre-IPO exposure vehicle, and the article provides zero evidence the fund's 0.84% fee is justified by alpha generation."
This article is promotional fluff masquerading as analysis. It conflates two separate bets: Baron Partners Fund (BPTRX) as a SpaceX proxy, and SpaceX's eventual IPO as a certainty. The fund is 33% SpaceX by allocation, but that stake is illiquid and valued at Baron's discretion—not marked-to-market daily. The article cites Baron's historical Tesla gains ($8B on $400M invested) as proof of skill, but cherry-picks one winner while ignoring the fund's broader performance and fee drag. Most critically: SpaceX's IPO timing is pure speculation. 'Months ahead' and 'first half of June' are vague, and Musk has repeatedly delayed or cancelled public offerings. Buying BPTRX now to get SpaceX exposure pre-IPO assumes (1) the IPO happens soon, (2) BPTRX's valuation reflects fair SpaceX value, and (3) the fund's other 67% holdings justify the 0.84% expense ratio.
If SpaceX IPO is delayed 18+ months, BPTRX holders are paying annual fees on illiquid SpaceX exposure while missing direct IPO allocation windows; worse, the fund's Tesla overweight (20.4%) could underperform if EV competition intensifies or macro sentiment shifts.
"Pre-IPO exposure to SpaceX via a mutual fund is a high-uncertainty bet with liquidity and valuation risk, contingent on an IPO that may be delayed or priced poorly."
Big takeaway: The article markets SpaceX exposure via Baron Partners Fund as if SpaceX were readily tradable pre-IPO. In reality, SpaceX remains private (not SPCE; Virgin Galactic trades under SPCE), so a 33% SpaceX allocation implies private-asset exposure with illiquidity and valuation risk baked in. The notion of an imminent IPO is speculative; even if a horizon exists, pricing is uncertain and secondary-market liquidity can evaporate. Also, the fund carries concentration and governance risk from Musk-tied holdings: a sharp negative turn in SpaceX news or Musk tweets could slam NAV. This is less about 'exposure' and more about a single-name levered bet.
SpaceX is private; the 33% allocation in a mutual fund exposes investors to illiquidity and private-valuation risk. If/when an IPO occurs, pricing and aftermarket performance may differ dramatically from private-market expectations, potentially crushing NAV.
"Investors are paying management fees on inflated, private-market valuations that lack the price discovery necessary to justify the fund's expense ratio."
Grok and Claude correctly highlight the valuation opacity, but everyone is ignoring the 'double-dip' risk: the fund’s expense ratio is calculated on the total NAV, including the massive, illiquid SpaceX stake. By paying a 1.3% fee on private assets that haven't faced public price discovery, investors are essentially subsidizing Baron’s research team to hold assets that might be significantly overvalued compared to current secondary market trades. This is a hidden tax on the 'backdoor' access.
"BPTRX mutual fund structure provides tax and liquidity advantages glossed over amid fee complaints."
Gemini's 'double-dip' fee point on illiquid SpaceX is valid but incomplete—BPTRX's mutual fund wrapper delivers daily liquidity and tax efficiency (qualified dividends from TSLA, deferred gains on privates until realization) unavailable in PE funds with K-1 headaches or illiquid secondaries. No public comp offers 33% SpaceX + 20% TSLA at 1.3% ER with Ron Baron's conviction sizing. That's the edge over direct bets.
"The mutual fund wrapper's tax efficiency is illusory when the underlying assets (SpaceX) generate no taxable events and carry embedded valuation risk."
Grok's tax-efficiency argument doesn't survive scrutiny. BPTRX holds illiquid privates with no realized gains to defer—the SpaceX stake generates zero qualified dividends. Meanwhile, the 1.3% ER compounds annually on unrealized private valuations that may never materialize at Baron's marks. A direct SpaceX secondary purchase (if available) or waiting for IPO pricing eliminates this fee drag entirely. Grok conflates mutual-fund liquidity with asset liquidity; the former is irrelevant if you're locked into illiquid holdings.
"BPTRX's 'daily liquidity' is not real liquidity due to potential side pockets/gating on SpaceX, making the fund riskier than its daily NAV suggests."
Responding to Grok: the "daily liquidity" of a private stake is not assured—SpaceX could be side-pocketed or gated, so the fund's 33% SpaceX exposure isn't truly liquid for redemptions. Daily NAVs may mask illiquidity risk and valuation lags. This isn't just a fee drag issue; it compounds liquidity risk during mispricing or delayed IPO timelines, potentially triggering large NAV swings and redemption pressure.
Panel Verdict
Consensus ReachedThe panel consensus is bearish on Baron Partners Fund (BPTRX) as a 'backdoor' to SpaceX IPO, citing high concentration risk, illiquidity, valuation opacity, and potentially high fees on private assets. They agree that investing in BPTRX for SpaceX exposure pre-IPO is speculative and risky.
None identified
High concentration risk (over 50% in SpaceX and Tesla) and illiquidity of private holdings